SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-23-069702
Filing Date
2023-12-12
Accepted
2023-12-12 16:19:01
Documents
4
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 PRE 14A apvo-2023-pre_14a_-_rev.htm PRE 14A 1195650
2 GRAPHIC img107616515_0.jpg GRAPHIC 156384
3 GRAPHIC img107616515_1.jpg GRAPHIC 110599
4 GRAPHIC img107616515_2.jpg GRAPHIC 95015
  Complete submission text file 0000950170-23-069702.txt   1694087
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37746 | Film No.: 231481467
SIC: 2834 Pharmaceutical Preparations